CT colonography screening compliance could be increased by 15 percent if covered by Medicare or third-party payers.
CT colonography screening compliance could be increased by 15 percent if covered by Medicare or third-party payers, said researchers in a study published in the July issue of American Journal of Roentgenology.
In 2009, the Centers for Medicare and Medicaid Services indicated that routine CT colonography would not be covered due to a lack of information that supported the effectiveness of the examinations.
To address this issue, researchers at the National Medical Center in Bethesda, Md, evaluated the outcomes of over 14,000 patients aged 65 years or older who underwent screening colonography between 2004 and 2009. It was found that the referral rate to colonoscopy among this patient group was 14 percent, similar to that of younger patients.
“The prevalence of neoplasia (abnormal growths of cells) detected by CT colonography was 9.3 percent in patients over the age of 65,” said Brooks Cash, MD, one of the study authors. He pointed out that potentially important extracolonic findings were identified in 2.9 percent of the study group. “The confirmation of low rates of referral to colonoscopy, the prevalence of advanced neoplasia and the prevalence of extracolonic findings makes CT colonography a valuable option for Medicare-aged patients.”
Addressing the issue of radiation dose during colonoscopy, another concern of the Centers for Medicare and Medicaid Services, Dr. Cash said, “The average effective radiation dose with CT colonography at the national Naval Medical Center was calculated to be 4.24 mSv per CT colonography examination. To put that into perspective, the average yearly radiation exposure of American adults is about 6.2 mSv.”
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.